Sales decline 22.64% to Rs 0.82 crore
Post allotment the shareholding of the company has increased by 7.46% to 68.81%.
Sales rise 38.47% to Rs 35.13 crore
Indias annual rate of inflation came in at 12.96% for the month of January, which is a continuous decline from 14.87% in November, 2021 and 13.56% in December, 2021. The high rate of inflation in January, 2022 is primarily due to rise in prices of mineral oils, crude petroleum & natural gas, basic metals, chemicals and chemical products, food articles etc as compared the corresponding […]
The month over month change in the WPI index for the month of January 2022 stood at 0.35 % as compared to December 2021.
Revenue for the quarter ended December 2021 was reported at Rs110.20 crore.
Aurobindo Pharma Ltd is quoting at Rs 707.85, up 1.11% on the day as on 12:49 IST on the NSE. The stock is down 24.07% in last one year as compared to a 10.86% spurt in NIFTY and a 5.12% spurt in the Nifty Pharma.
Revenue grew by 57% yoy to Rs99 crore during the quarter as the company added 778 new clients and reported overall 215% growth in new contracts compared to the previous fiscal.
Sales rise 41.43% to Rs 487.59 crore
Sales decline 18.43% to Rs 28.72 crore

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.